This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shirai, T. Articles by Ito, N. Search for Related Content PubMed PubMed Citation Articles by Shirai, T. Articles by Ito, N.

Induction of Invasive Carcinomas in the Accessory Sex Organs Other Than the Ventral Prostate of Rats Given 3,2'-Dimethyl-4-aminobiphenyl and Testosterone Propionate¹

First Department of Pathology, Nagoya City University Medical School, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan

The promotion effects of testosterone propionate (TP) on prostate carcinogenesis were investigated in F344 rats given the prostatic carcinogen, 3,2'-dimethyl-4-aminobiphenyl (DMAB). One group of animals received s.c. DMAB injections at a dose of 50 mg/kg body weight at 2-week intervals for a total of 10 injections along with s.c. implantations of TP-containing Silastic tubes. A second experimental group of rats was given DMAB at the same dose and intervals but each injection of DMAB was combined with 3 prior consecutive daily 100-mg/kg body weight s.c. injections of TP. After cessation of carcinogen administration, animals in these two groups received TP implants from week 21 to the end of the experiment. All surviving animals were killed at week 56 and accessory sex gland tumor incidences were compared to those in DMAB alone and other appropriate control groups.

The groups given TP plus DMAB and subsequent long term administration of TP developed lesions of the dorsolateral prostate, seminal vesicles, and coagulating glands which were all invasive adenocarcinomas. Incidences were 84.2% (16 of 19 rats) and 66.7% (12 of 18 rats), respectively. Macroscopic large tumors were induced in 13 animals among which 8 demonstrated metastasis to the abdominal cavity, liver, or lung. None of the control groups except for the group given TP injections plus DMAB had equivalent tumors. Development of carcinomas of the ventral prostate, which were all of in situ type, were not increased by subsequent treatment with TP.

These data thus clearly showed that TP can exert strong enhancing effects on tumor development in the dorsolateral prostate, seminal vesicles, and coagulating glands but not in the ventral prostate.

¹ This work was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture and from the Ministry of Health and Welfare of Japan, by a Grant-in-Aid from the Ministry of Health and Welfare for the Comprehensive 10 Years Strategy for Cancer Control, Japan; and by a grant from the Society for Promotion of Cancer Research of Aichi Prefecture.

² To whom requests for reprints should be addressed.

Received 10/12/90. Accepted 12/ 6/90.

This article has been cited by other articles:

				S. Yamashita, S. Takahashi, N. McDonell, N. Watanabe, T. Niwa, K. Hosoya, Y. Tsujino, T. Shirai, and T. Ushijima Methylation Silencing of Transforming Growth Factor-{beta} Receptor Type II in Rat Prostate Cancers Cancer Res., April 1, 2008; 68(7): 2112 - 2121. [Abstract] [Full Text] [PDF]

				M. Pollard and M. A. Suckow Hormone-Refractory Prostate Cancer in the Lobund-Wistar Rat Experimental Biology and Medicine, September 1, 2005; 230(8): 520 - 526. [Abstract] [Full Text] [PDF]

				A. Tsujimura, Y. Koikawa, S. Salm, T. Takao, S. Coetzee, D. Moscatelli, E. Shapiro, H. Lepor, T.-T. Sun, and E. L. Wilson Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis J. Cell Biol., June 24, 2002; 157(7): 1257 - 1265. [Abstract] [Full Text] [PDF]

				K. Imaida, M. Sano, S. Tamano, M. Asamoto, K. Ogawa, M. Futakuchi, and T. Shirai Organ dependent enhancement of rat 3,2'-dimethyl-4-aminobiphenyl (DMAB) carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): positive effects on the intestine but not the prostate Carcinogenesis, August 1, 2001; 22(8): 1295 - 1299. [Abstract] [Full Text] [PDF]

				K. Imaida, S. Tamano, K. Kato, Y. Ikeda, M. Asamoto, S. Takahashi, Z. Nir, M. Murakoshi, H. Nishino, and T. Shirai Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis Carcinogenesis, March 1, 2001; 22(3): 467 - 472. [Abstract] [Full Text] [PDF]

				M. C. Bosland Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66. [Abstract] [Full Text] [PDF]

				T. Yamada, T. Kunimatsu, H. Sako, S. Yabushita, T. Sukata, Y. Okuno, and M. Matsuo Comparative Evaluation of a 5-Day Hershberger Assay Utilizing Mature Male Rats and a Pubertal Male Assay for Detection of Flutamide's Antiandrogenic Activity Toxicol. Sci., February 1, 2000; 53(2): 289 - 296. [Abstract] [Full Text] [PDF]

				P. P. Banerjee, S. Banerjee, J. M. Lai, J. D. Strandberg, B. R. Zirkin, and T. R. Brown Age-Dependent and Lobe-Specific Spontaneous Hyperplasia in the Brown Norway Rat Prostate Biol Reprod, November 1, 1998; 59(5): 1163 - 1170. [Abstract] [Full Text]